RWDD2B
RWD domain-containing protein 2B
Also known as: C21orf6, GL011, RWD2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P57060
- Gene
- RWDD2B
- Ensembl
- ENSG00000156253
- Chromosome
- 21
- Canonical length
- 319 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for RWDD2B in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>P57060|RWDD2B
1 MKIELSMQPW NPGYSSEGAT AQETYTCPKM IEMEQAEAQL AELDLLASMF PGENELIVND
61 QLAVAELKDC IEKKTMEGRS SKVYFTINMN LDVSDEKMAM FSLACILPFK YPAVLPEITV
121 RSVLLSRSQQ TQLNTDLTAF LQKHCHGDVC ILNATEWVRE HASGYVSRDT SSSPTTGSTV
181 QSVDLIFTRL WIYSHHIYNK CKRKNILEWA KELSLSGFSM PGKPGVVCVE GPQSACEEFW
241 SRLRKLNWKR ILIRHREDIP FDGTNDETER QRKFSIFEEK VFSVNGARGN HMDFGQLYQF
301 LNTKGCGDVF QMFFGVEGQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RWDD2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 3.3 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 3.3 nTPM
- tongue: 2.7 nTPM
- heart muscle: 1.3 nTPM
- skin: 1.2 nTPM
- cerebral cortex: 1.1 nTPM
- liver: 1.1 nTPM
Single-cell type
- early primary spermatocytes: 40 nCPM
- late primary spermatocytes: 39 nCPM
- hepatocytes: 30 nCPM
- parietal cells: 25 nCPM
- megakaryocytes: 25 nCPM
- myonuclei: 25 nCPM
Immune cell
- basophil: 3.1 nTPM
- neutrophil: 1.2 nTPM
- memory B-cell: 0.8 nTPM
- non-classical monocyte: 0.7 nTPM
- gdT-cell: 0.6 nTPM
- naive B-cell: 0.6 nTPM
Brain region
- cerebral cortex: 5.2 nTPM
- white matter: 5.2 nTPM
- cerebellum: 4.9 nTPM
- pons: 4.8 nTPM
- hippocampal formation: 4.6 nTPM
- basal ganglia: 4.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RWDD2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RWDD2B as an antibody target. Whether an autoantibody or antibody against RWDD2B could matter depends on whether native RWDD2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RWDD2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RWDD2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...